Welcome to the latest edition of NORML’s Weekly Legislative Roundup! This week, the U.S. Drug Enforcement Administration placed CBD medication Epidiolex in Schedule V, the least restrictive category of the Controlled Substances Act. The move does not apply to CBD itself or other non-FDA-approved extracts containing it. U.S. Customs and Border Protection released an official […]
Welcome to the latest edition of NORML’s Weekly Legislative Roundup! This week, reports circulated that the US Customs and Border Protection Agency will enforce a federal policy denying entry into the United States any individual involved in Canada’s burgeoning marijuana market. Under the policy, US officials are to bar entry to Canadians who acknowledge having […]
Welcome to the latest edition of NORML’s Weekly Legislative Roundup! The U.S. House Judiciary Committee approved legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions […]
Welcome to the latest edition of NORML’s Weekly Legislative Roundup! U.S. Senators Brian Schatz (D-HI) and Bill Nelson (D-FL) introduced legislation this week, The Veterans Medical Marijuana Safe Harbor Act, to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions. The measure would allow the Department of […]
Welcome to the latest edition of NORML’s Weekly Legislative Roundup! At the state level, North Dakota’s secretary of state’s office determined that activists collected enough signatures to qualify a far-reaching marijuana legalization initiative for the November ballot. The campaign behind one Missouri medical cannabis initiative filed lawsuits seeking to block two other measures from appearing on […]